However, interestingly, low signal levels in two lectin assays from serum, namely, ITGA2–UEA and ITGB4–MAA, were significantly associated with both tumor recurrence and poor radiotherapy response in ROC analysis as well (Figure 4D). This evidence concerns the gene ITGB4 and neoplasm.